Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2025 03:00 ET | Source: Fluence; Varco Energy

Varco Energy and Fluence Advance 142.5 MW Sizing John Energy Storage Project: Phase 1 Fully Operational, Launch of Phase 2

Varco Energy and Fluence Advance 142.5 MW Sizing John Energy Storage Project: Phase 1 Fully Operational, Launch of Phase 2
December 08, 2025 03:00 ET | Source: VEON Ltd.

VEON’s Beeline Kazakhstan Breaks Ground for Hyper Cloud Data Center to Offer Sovereign Enterprise, AI and Digital Services

Dubai and Almaty, December 8, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), today announced that Beeline Kazakhstan has begun construction of the new Hyper Cloud data center in...
December 08, 2025 02:01 ET | Source: Golden Matrix Group (GMGI)

Global Matrix Group (NASDAQ: GMGI) Appoints Mr William Scott to Build on Success and Accelerate Growth

Golden Matrix Group Inc. (NASDAQ: GMGI), a global provider of online gaming platforms announces planned leadership transition that aligns with growth plans
December 08, 2025 02:00 ET | Source: Pharming Group N.V.

Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit

Pharming to participate in Oppenheimer Movers in Rare Disease Summit on Dec 11 in NYC. Chief Medical Officer Anurag Relan in fireside chat at 1:50 PM ET.
December 08, 2025 02:00 ET | Source: Bowman Consulting Group, Ltd.

Bowman Acquires RPT Alliance, Broadens Energy Engineering to Include Utility-Scale Power Generation for Data Centers and Industrial Facilities

Bowman acquires RPT Alliance, adding specialized natural gas transmission and power generation engineering services.
December 08, 2025 01:30 ET | Source: Cellectis Inc.

ASH 2025 : Cellectis présente son plan de développement pour renforcer les taux de réponse élevés obtenus avec éti-cel dans le LNH en rechute ou réfractaire

Éti-cel a montré un taux de réponse globale (ORR) de 88 % et un taux de réponse complète (CR) de 63 % (n=8) au niveau de dose actuel chez des patients atteints de LNH en rechute ou réfractaire après...
December 08, 2025 01:30 ET | Source: Cellectis Inc.

ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL

Eti-cel showed an 88% ORR and 63% CR (n=8) at current dose level in r/r NHL after ≥2 prior lines of therapyIn vivo data suggest IL-2 may further enhance response rates and optimize eti-cel expansion...
December 07, 2025 21:09 ET | Source: Faraday Future

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The FX Super One First Pre-Production Vehicles Roll-off Ceremony is Scheduled for December 21 at the Company’s Hanford, CA Factory

The first batch of knockdowns for FX Super One MPV have successfully arrived at the Port of Long Beach, cleared customs and have commenced delivery to the Company’s manufacturing facility in Hanford,...
December 07, 2025 20:10 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL

ASH 2025 | Ascentage Pharma Presents Encouraging Data from Phase Ib/II Study of Bcl-2 Inhibitor Lisaftoclax in Venetoclax–Exposed Patients with Myeloid Malignances

Preliminary clinical evidence of Lisaftoclax overcoming venetoclax resistance in myeloid malignancies with a 31.8% overall response rate(ORR) in this subgroup of patients80% ORR achieved in newly...
December 07, 2025 19:00 ET | Source: HUTCHMED (China) Limited

HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that following the contract renewal...